On November 30, 2023 Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) reported that it will host a conference call and simultaneous webcast to provide an update on the company’s hematology portfolio on Thursday, December 14, 2023 at 8:30 AM ET (Press release, Regeneron, NOV 30, 2023, View Source [SID1234638070]). This investor call follows Regeneron data updates presented at the 65th American Society of Hematology (ASH) (Free ASH Whitepaper) Annual Meeting and Exposition, from December 9-12, 2023.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The webcast may be accessed from the "Investors & Media" page of Regeneron’s website at View Source To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay and transcript of the webcast will be archived on the Company’s website for at least 30 days.